JDVPX
Price
$24.25
Change
+$0.19 (+0.79%)
Updated
Jul 3 closing price
Net Assets
18.12B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

JDVPX vs VIVAX

Header iconJDVPX vs VIVAX Comparison
Open Charts JDVPX vs VIVAXBanner chart's image
JHancock Disciplined Value R2
Price$24.25
Change+$0.19 (+0.79%)
VolumeN/A
Net Assets18.12B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
JDVPX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDVPX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVPX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. JDVPX (18.1B). VIVAX pays higher dividends than JDVPX: VIVAX (2.06) vs JDVPX (0.59). JDVPX was incepted earlier than VIVAX: JDVPX (13 years) vs VIVAX (33 years). JDVPX (1.11) is less costly to investors than VIVAX (0.17). JDVPX is a more actively managed with annual turnover of: 48.00 vs. VIVAX (9.00). JDVPX has a lower initial minimum investment than VIVAX: JDVPX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. JDVPX (-0.11). VIVAX return over 5 years is better than : 80.14 vs. JDVPX (44.82).
JDVPXVIVAXJDVPX / VIVAX
Total Expense Ratio1.100.17647%
Annual Report Gross Expense Ratio1.110.17653%
Fund Existence13 years33 years-
Gain YTD8.1626.209131%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets18.1B189B10%
Annual Yield % from dividends0.592.0628%
Returns for 1 year-0.1112.04-1%
Returns for 3 years16.8435.1648%
Returns for 5 years44.8280.1456%
Returns for 10 years33.88115.7429%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.